Prognostic significance of c-erbB-2/HER2 expression in advanced uterine cervical carcinoma with para-aortic lymph node metastasis treated with radiation therapy

This publication has 34 references indexed in Scilit:

• The Role of p53, MDM2 and c-erb B-2 Oncoproteins, Epidermal Growth Factor Receptor and Proliferation Markers in the Prognosis of Urinary Bladder Cancer
  Pathology - Research and Practice, 1997
• A Hierarchical Network of Interreceptor Interactions Determines Signal Transduction by Neu Differentiation Factor/Neuregulin and Epidermal Growth Factor
  Molecular and Cellular Biology, 1996
• The type 1 (EGFR-related) family of growth factor receptors and their ligands
  Progress in Growth Factor Research, 1992
• High-dose-rate remote afterloading intracavitary radiation therapy for cancer of the uterine cervix. A 20-year experience
  Cancer, 1992
• Therapy of small breast cancer: A prospective study on 1036 patients with special emphasis on prognostic factors
  International Journal of Radiation Oncology*Biology*Physics, 1992
• Extended-field radiation therapy in early-stage cervical carcinoma: Survival and complications
  Gynecologic Oncology, 1991
• The Product of the Human c- erb B-2 Gene: a 185-Kilodalton Glycoprotein with Tyrosine Kinase Activity
  Science, 1986
• Similarity of protein encoded by the human c-erb-B-2 gene to epidermal growth factor receptor
  Nature, 1986
• The neu Gene: an erb B-Homologous Gene Distinct from and Unlinked to the Gene Encoding the EGF Receptor
  Science, 1985
• The lymphatic spread of carcinoma of the cervix and of the body of the uterus
  American Journal of Obstetrics and Gynecology, 1949